Last 12 months
Inside the activity.
15 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 12 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 02:48 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 29,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000006 · wf-form4_167712047950850.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,161 Read SEC document |
| December 29, 2022 Filed Dec 30, 2022 22:16 UTC |
Caligan Partners LP10% owner
|
OtherCommon Stock, $0.001 par value per share (Common Stock) | 2,868,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-22-005341 · ownership.xml · nonDerivative · entry 1 Caligan Partners LP · CIK 0001727492 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,576,799 F1 · kind: This transaction represents an in-kind distribution by certain funds and accounts to which Caligan Partners LP ("Caligan") serves as the investment manager. F1 · price: This transaction represents an in-kind distribution by certain funds and accounts to which Caligan Partners LP ("Caligan") serves as the investment manager. F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| December 20, 2022 Filed Jan 20, 2023 22:24 UTC |
Davis Jeremy StevenSVP Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000002 · wf-form4_167425346769614.xml · derivative · entry 1 Davis Jeremy Steven · CIK 0001919871 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of LAB common stock. F2 · derivative.exercise_date: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023. F2 · derivative.expiration_date: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023. Read SEC document |
| December 20, 2022 Filed Jan 20, 2023 22:26 UTC |
JOG VIKRAMChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000004 · wf-form4_167425356896927.xml · derivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F2 · derivative.exercise_date: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023. F2 · derivative.expiration_date: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,238 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,954 Underlying: Common Stock · 2,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,306 Underlying: Common Stock · 3,131 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Tax withholdingCommon Stock | 2,681 | $1.43 | $3,833.83 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,904 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 3,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,475 Underlying: Common Stock · 2,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,345 Underlying: Common Stock · 2,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,437 Underlying: Common Stock · 3,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Tax withholdingCommon Stock | 2,681 | $1.56 | $4,182.36 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,826 Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC |
JOG VIKRAMChief Financial Officer
|
Exercise / conversionCommon Stock | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 15:10 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock | 255,173 | $1.75 | $446,552.75 |
DisclosureSEC source: 0000902664-22-003823 · ownership.xml · nonDerivative · entry 2 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,444,836 F2 · price: Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.71 to $1.77. F4 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. F3 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 15:10 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock, $0.001 par value per share ("Common Stock") | 46,009 | $1.74 | $80,055.66 |
DisclosureSEC source: 0000902664-22-003823 · ownership.xml · nonDerivative · entry 1 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,189,663 F1 · price: Price is the volume weighted average price of all trades by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $1.70 to $1.75. F4 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. F3 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| August 02, 2022 Filed Aug 2, 2022 21:27 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock | 272,618 | $1.64 | $447,093.52 |
DisclosureSEC source: 0000902664-22-003778 · ownership.xml · nonDerivative · entry 3 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,143,654 F3 · price: Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.49 to $1.70. F5 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. F4 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 21:27 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock | 210,200 | $1.48 | $311,096.00 |
DisclosureSEC source: 0000902664-22-003778 · ownership.xml · nonDerivative · entry 2 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,871,036 F2 · price: Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.40 to $1.52. F5 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. F4 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:27 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock, $0.001 par value per share (Common Stock) | 137,648 | $1.42 | $195,460.16 |
DisclosureSEC source: 0000902664-22-003778 · ownership.xml · nonDerivative · entry 1 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,660,836 F1 · price: Price is the volume weighted average price of all trades by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $1.37 to $1.45. F5 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. F4 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:06 UTC |
Burbach Gerhard FDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000080 · wf-form4_165550356380329.xml · derivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:06 UTC |
Burbach Gerhard FDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000080 · wf-form4_165550356380329.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,827 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:11 UTC |
Colston BillDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000082 · wf-form4_165550386102701.xml · derivative · entry 2 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:11 UTC |
Colston BillDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000082 · wf-form4_165550386102701.xml · nonDerivative · entry 1 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,288 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC |
Madaus Martin DDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000079 · wf-form4_165550354111671.xml · derivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000079 · wf-form4_165550354111671.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,766 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC |
Witney FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000078 · wf-form4_165550351788011.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC |
Witney FrankDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000078 · wf-form4_165550351788011.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,766 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC |
Paya Carlos VDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000077 · wf-form4_165550349980323.xml · derivative · entry 2 Paya Carlos V · CIK 0001606244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC |
Paya Carlos VDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000077 · wf-form4_165550349980323.xml · nonDerivative · entry 1 Paya Carlos V · CIK 0001606244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,468 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:04 UTC |
Clague LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000075 · wf-form4_165550345180060.xml · derivative · entry 2 Clague Laura · CIK 0001388773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:04 UTC |
Clague LauraDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000075 · wf-form4_165550345180060.xml · nonDerivative · entry 1 Clague Laura · CIK 0001388773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,415 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control. F2 · balance_after: Represents Restricted Stock Units with respect to which the Reporting Person has deferred settlement as described above. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:04 UTC |
Casdin EliDirector
|
GrantStock Option (Right to Buy) · Derivative | 42,571 | $1.86 Strike: $1.86 | $79,182.06 |
DisclosureSEC source: 0001162194-22-000076 · wf-form4_165550347430647.xml · derivative · entry 2 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:04 UTC |
Casdin EliDirector
|
GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000076 · wf-form4_165550347430647.xml · nonDerivative · entry 1 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,766 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 13:06 UTC |
Caligan Partners LP10% owner · See Remarks
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock, $0.001 par value per share ("Common Stock") | 100,000 | $1.70 | $170,000.00 |
DisclosureSEC source: 0000902664-22-003296 · ownership.xml · nonDerivative · entry 1 Caligan Partners LP · CIK 0001727492 · 10% owner · See Remarks JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,523,188 F1 · price: Price is the volume weighted average price of all trades by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $1.64 to $1.75. F3 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 18:01 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock | 250,000 | $1.98 | $495,000.00 |
DisclosureSEC source: 0000902664-22-003177 · ownership.xml · nonDerivative · entry 2 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,423,188 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $1.92 to $2.02. F4 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 18:01 UTC |
Caligan Partners LP10% owner
JOHNSON DAVID EDWARD10% owner
|
PurchaseCommon Stock, $0.001 par value per share ("Common Stock") | 200,000 | $1.92 | $384,000.00 |
DisclosureSEC source: 0000902664-22-003177 · ownership.xml · nonDerivative · entry 1 Caligan Partners LP · CIK 0001727492 · 10% owner JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,173,188 F1 · price: Price is the volume weighted average selling price of all sales by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $1.83 to $2.00. F4 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 22:01 UTC |
Khadder NicholasSVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 3,341 | $1.61 | $5,368.99 |
DisclosureSEC source: 0001162194-22-000065 · wf-form4_165429367255247.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,480 F1 · kind: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 9,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · derivative · entry 11 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,584 Underlying: Common Stock · 9,527 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F6 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. F6 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · derivative · entry 10 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. F5 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · derivative · entry 9 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,735 Underlying: Common Stock · 2,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · derivative · entry 8 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,711 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · derivative · entry 7 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F2 · derivative.exercise_date: On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Tax withholdingCommon Stock | 14,431 | $2.05 | $29,583.55 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · nonDerivative · entry 6 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,157 Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC |
Kreger Bradley AllenSVP, Global Operations
|
Exercise / conversionCommon Stock | 9,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · nonDerivative · entry 5 Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.